
Nadropar 2850IU Injection
Marketer
Bharat Serums & Vaccines Ltd
Salt Composition
Nadroparin (2850IU)
Overview Nadropar 2850IU Injection
Nadropar 2850 IU Injection is an anti-clotting medication preventing and treating dangerous blood clots. It inhibits clot growth and formation in vital areas like the lungs, legs, heart, and brain. Administration is solely by a healthcare professional (doctor or nurse). Dosage and treatment duration depend on individual health, response to treatment, underlying condition, age, and weight. Continued injections are crucial, even without symptoms, to avert future complications; discontinuation risks clot formation. Potential side effects include bleeding, injection site reactions (including hematoma), and elevated liver enzymes. Patients should minimize bleeding risks by avoiding activities increasing injury potential (e.g., exercising caution with sharp objects). Prior to treatment, inform your doctor of conditions such as high blood pressure, diabetes, or recent stroke. Avoid use if actively bleeding. Medication interactions exist; disclose all other medications to your doctor. Consult your physician regarding Nadropar 2850 IU Injection use during pregnancy or breastfeeding.
Uses of Nadropar 2850IU Injection
Preventing and managing blood clots
Major Benefits of Nadropar 2850IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Nadropar 2850IU Injection:
- Injection site reaction
- Bleeding
- Injection site hematoma
- Increased liver enzymes
How to use Nadropar 2850IU Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Nadropar 2850IU Injection works:
Nadroparin 2850 IU injection acts as a blood thinner, inhibiting the development of potentially dangerous thrombi.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Nadropar 2850IU Injection may pose safety risks; medical advice is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Nadropar 2850IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Nadropar 2850IU Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Nadropar 2850IU Injection's effect on driving ability is undetermined. Refrain from driving should you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with significant kidney impairment, administering Nadropar 2850IU Injection requires careful consideration. A modified dosage of Nadropar 2850IU Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Nadropar 2850IU Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Nadropar 2850IU Injection :
Omit a Nadropar 2850IU Injection dose? Seek your physician's advice.
Facts to Know About Nadropar 2850IU Injection
| Label | Value |
|---|---|
| Chemical Category | Low-molecular-weight heparin |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Category | Low-molecular-weight heparin (LMWH) |
